Brief: BB Biotech Q2 Net Loss Of Chf 100 Mn In Q2, FX Main Drag
July 25 (Reuters) - BB BIOTECH AG BION.S: NET LOSS OF CHF 100 MN IN Q2, FX MAIN DRAG Q2 SHARE PRICE +10.2 % USD / -1.1% CHF / +0.8% EUR; DISCOUNT TO NAV TIGHTENS TO 10.5% PORTFOLIO STEADY AT 23 COMPANIES, EXITED ESPERION THERAPEUTICS Q2 NAV ROSE 5.8% IN USD - BEATING NBI BY 5.9 POINTS - BUT TRANSLATED INTO -5.1% IN CHF AND -2.8% IN EUR Source text: ID:nEQ8J0lbNa Further company coverage: BION.S (Gdansk Newsroom) ((((gdansk.newsroom@thomsonreuters.com ; +48 587785269; ));))
Recent news on Bb Biotech AG
See all newsBrief: BB Biotech Reports Net Profit Of CHF 451 Mln In Q2 2026
Switzerland's BB Biotech Q1 net loss narrows amid portfolio rotation
Brief: BB Biotech Reports Q1 Net Loss Of CHF 21 Million
Brief: BB BIOTECH Q1 Net Income CHF -21 Million
Brief: BB Biotech Says All Proposals Of Board Of Directors Approved At AGM